ASC Therapeutics “Advanced Genome Editing, Gene & Cell Therapy Platforms in the US and China” won the first prize

ASC Therapeutics “Advanced Genome Editing, Gene & Cell Therapy Platforms in the US and China” won the first prize of the “2021 Fifth Forum For New Drug R&D And Bio-Pharma Projects Roadshow” held on June 24, 2021 in Nanjing Biomedical Valley.

Our CEO Ruhong Jiang, PhD, described our three platforms for second-generation gene therapy, CRISPR therapy and allogeneic cell therapy for hereditary, immune and hematooncology diseases. # #genetherapy #celltherapy #biotech #immunotherapy #crispr

More details here:

https://mp.weixin.qq.com/s/Gk7BG-papATVA9yfhyc7JA

Contacts

Oscar Segurado